Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta)

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Dow, Geoffrey S ^a   Gettayacamin, Montip ^b   Hansukjariya, Pranee ^b   Imerbsin, Rawiwan ^b   Komcharoen, Srawuth ^b   Sattabongkot, Jetsumon ^b   Kyle, Dennis ^c   Milhous, Wilbur ^c   Cozens, Simon ^d   Kenworthy, David ^d   Miller, Anne ^e   Veazey, Jim ^f   Ohrt, Colin ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b U S ARMY   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d GLAXOSMITHKLINE   (United Kingdom)

^e GLAXOSMITHKLINE   (United States)

^f MCMR AT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; CHLOROQUINE; DEETHYLCHLOROQUINE; MEFLOQUINE; TAFENOQUINE; AMINOQUINOLINE DERIVATIVE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE; QUININE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG EFFICACY; INDIAN; LIQUID CHROMATOGRAPHY; MALARIA; MASS SPECTROMETRY; MONOTHERAPY; NONHUMAN; PLASMODIUM CYNOMOLGI; PREMEDICATION; RHESUS MONKEY; ANIMAL; CHEMISTRY; DISEASE MODEL; DRUG COMBINATION; HUMAN; MACACA MULATTA; MALE; METHODOLOGY; PARASITOLOGY; PLASMA; PRIMATE DISEASE; TREATMENT OUTCOME;

AMINOQUINOLINES; ANIMALS; ANTIMALARIALS; ARTEMISININS; CHLOROQUINE; CHROMATOGRAPHY, LIQUID; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FLUORENES; HUMANS; MACACA MULATTA; MALARIA; MALE; MASS SPECTROMETRY; MEFLOQUINE; PLASMA; PLASMODIUM CYNOMOLGI; PRIMATE DISEASES; QUININE; TREATMENT OUTCOME;

EID: 79960850180     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-212     Document Type: Article

References (24)

1. th Amendment to the Declaration of Helsinki. Dow GS, Magill AJ, Ohrt C, Ther Clin Risk Manag 2008 4 803 819 19209263
2. Treatment of acute vivax malaria with tafenoquine. Nasveld P, Kitchener S, Trans R Soc Trop Med Hyg 2005 99 2 5 10.1016/j.trstmh.2004.01.013 15550254 (Pubitemid 39517029)
3. 8-Aminoquinolines. Brueckner R, Ohrt C, Baird J, Milhous W, Antimalarial chemotherapy: mechanisms of action, resistance, and new directions in drug discovery NJ: The Humana Press, Inc, Rosenthal PJ, 2001
4. A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria. Shanks GD, Oloo AJ, Aleman GM, Ohrt C, Klotz FW, Braitman D, Horton J, Brueckner R, Clin Infect Dis 2001 33 1968 1974 10.1086/324081 11700577 (Pubitemid 33152389)
5. WR 238605, chloroquine, and their combinations as blood schizonticides against a chloroquine-resistant strain of Plasmodium vivax in Aotus monkeys. Obaldia N, Rossan RN, Cooper RD, Kyle DE, Nuzum EO, Rieckmann KH, Shanks GD, Am J Trop Med Hyg 1997 56 508 510 9180599 (Pubitemid 27230071)
6. Population pharmacokinetics of mefloquine in patients with acute falciparum malaria. Simpson JA, Price R, ter Kuile F, Teja-Isavatharm P, Nosten F, Chongsuphajaisiddhi T, Looareesuwan S, Aarons L, White NJ, Clin Pharmacol Ther 1999 66 472 484 10.1016/S0009-9236(99)70010-X 10579474
7. Coartem: the journey to the clinic. Premji ZG, Malar J 2009 8 Suppl 1 3 10.1186/1475-2875-8-S1-S3 19917073
8. The activity if a repository form of 4,6-diamino-1(p-chlorophenyl)-1,2- dihydro-2,2-dimethyl-S-triazine against infections with Plasmodium cynomolgi. Schmidt LH, Rossan RN, Fisher KF, Am J Trop Med Hyg 1963 12 494 503 14044759
9. Plasmodium cynomolgi infections in the rhesus monkey. Schmidt LH, Fradkin R, Genther CS, Rossan RN, Squires W, Hughes HB, Am J Trop Med Hyg 1982 31 Supplement 646 665
10. Biological screening in the U.S. Army antimalarial drug development program. Kenneth EK, Rothe WE, Am J Trop Med Hyg 1975 24 174 178 804264
11. Sporozoite-induced Plasmodium cynomolgi infections in captive born Macaca fascicularis. Ward GS, Hansukjariya P, Wongsepradit S, Andre RG, Davidson DE, Southeast Asian J Trop Med Public Health 184 15 12 18
12. Institute of Laboratory Animal Resources, Guide for the Care and Use of Laboratory Animals Washington, DC; National Academic Press 1996
13. Evaluating new antimalarial drugs against trophozoite induced Plasmodium cynomolgi malaria in rhesus monkeys. Davidson DE Jr, Johnsen DO, Tanticharoenyos P, Hickman RL, Kinnamon KE, Am J Trop Med Hyg 1976 25 26 33 816211
14. Causal prophylactic and radical curative activity of WR182393 (a guanylhydrazone) against Plasmodium cynomolgi in Macaca mulatta. Corcoran KD, Hansukjariya P, Sattabongkot J, Ngampochjana M, Edstein MD, Smith CD, Shanks GD, Milhous WK, Am J Trop Med Hyg 1993 49 473 477 8214277 (Pubitemid 23320083)
15. Malaria causal prophylactic activity of imidazolidinedione derivatives. Guan J, Wang X, Smith K, Ager A, Gettayacamin M, Kyle DE, Milhous WK, Kozar MP, Magill AJ, Lin AJ, J Med Chem 2007 50 6226 6231 10.1021/jm7009815 17967003
16. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand. Vijaykadga S, Rojanawatsirivej C, Congpoung K, Wilairatana P, Satimai W, Uaekowitchai C, Pumborplub B, Sittimongkol S, Pinyorattanachote A, Prigchoo P, Southeast Asian J Trop Med Public Health 2004 35 566 569 15689067 (Pubitemid 39486422)
17. Novartis, Coartem Prescribing Information East Hanover, New Jersey; Novartis 2009
18. Fleiss JL, Statistical methods for rates and proportions New York, NY; John Wiley & Sons Inc. 2 1981 24 26
19. The saw-toothed behavior of power versus sample size and software solutions: single binomial proportion using exact methods. Chernick MR, Liu CV, American Statistician 2001 56 149 155
20. Spectrophotometric determination of oxy-, carboxy-, met- and sulfhemoglobin in capillary blood. Norgaard-Pederson B, Siggaard-Anderson O, Rem J, Clin Chim Acta 1972 42 85 100 10.1016/0009-8981(72)90380-4 4654866
21. Pharmacokinetics and efficacy of piperaquine and chloroquine in Malenesian children with uncomplicated malaria. Karunajeewa H, Ilett K, Meuller I, Siba P, Law I, Page-Sharp M, Lin E, Lammev J, Batty K, Davis T, Antimicrob Agents Chem 2008 52 237 243 10.1128/AAC.00555-07
22. Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand. Walsh DS, Looareesuwan S, Wilairatana P, Heppner DG Jr, Tang DB, Brewer TG, Chokejindachai W, Viriyavejakul P, Kyle DE, Milhous WK, Schuster BG, Horton J, Braitman DJ, Brueckner RP, J Infect Dis 1999 180 1282 7 10.1086/315034 10479159 (Pubitemid 30070215)
23. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse. Walsh DS, Wilairatana P, Tang DB, Heppner DG Jr, Brewer TG, Krudsood S, Silachamroon U, Phumratanaprapin W, Siriyanonda D, Looareesuwan S, Clin Infect Dis 2004 39 1095 103 10.1086/424508 15486831 (Pubitemid 40169305)
24. Potentiation of the curative action of primaquine in vivax malaria by quinine and chloroquine. Alving AS, Arnold J, Hockwald RS, Clayman CB, Dern RJ, Beutler E, Flanagan CL, Lab Clin Med 1955 46 301 306